findmyKOL

Ivan Suner, MD

Enriched profile

Managing Partner and Director of Clinical Research, Retina Associates of Florida; Clinical Associate Professor, University of South Florida Department of Ophthalmology · Retina Associates of Florida

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Tampa, FL · Southeast · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Ivan Suner is Managing Partner and Director of Clinical Research, Retina Associates of Florida; Clinical Associate Professor, University of South Florida Department of Ophthalmology at Retina Associates of Florida. OpenAlex indexes 64 publications with 3,839 citations (h-index 25); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Ivan J. Suñer, MD, is Managing Partner and Director of Clinical Research, Retina Associates of Florida. The public record shows 64 publications with 3,839 citations (h-index 25), centered on Retinal Diseases and Treatments, Ophthalmology and Visual Impairment Studies, Ocular Diseases and Behçet’s Syndrome. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 31 companies.

  • Most recent indexed publication: 2026 · Clinical ophthalmology (Auckland, N.Z.)
  • Top research focus: Retinal Diseases and Treatments
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 31 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Edema2 trialsMacular Edema2 trialsDiabetic Complications1 trialDiabetic Retinopathy / DME1 trialRetinal Vein Occlusion1 trialMacular Degeneration (AMD)

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsOphthalmology and Visual Impairment StudiesOcular Diseases and Behçet’s SyndromeRetinal and Optic ConditionsRetinal Imaging and Analysis

Drugs & molecules

across trials, industry payments and publications
Lucentisgeneric · RanibizumabClinical trials—Industry payments65Publications11Syfovregeneric · PegcetacoplanClinical trials—Industry payments63Publications1Dextenzageneric · DexamethasoneClinical trials—Industry payments16Publications2Beovugeneric · BrolucizumabClinical trials—Industry payments3Publications1Vabysmogeneric · FaricimabClinical trials—Industry payments96Publications—Eyleageneric · AfliberceptClinical trials—Industry payments47Publications—Iluviengeneric · FluocinoloneClinical trials—Industry payments30Publications—EYLEA HDClinical trials—Industry payments25Publications—Xiperegeneric · TriamcinoloneClinical trials—Industry payments17Publications—Izervaygeneric · Avacincaptad pegolClinical trials—Industry payments6Publications—Tepezzageneric · TeprotumumabClinical trials—Industry payments4Publications—Xiidrageneric · LifitegrastClinical trials—Industry payments4Publications—

Works with

trial sponsors and companies reporting payments
Genentech USA, Inc.Clinical trials—Industry payments130Apellis Pharmaceuticals, Inc.Clinical trials—Industry payments79Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments43Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments27Bausch & Lomb Americas Inc.Clinical trials—Industry payments20Alimera Sciences, Inc.Clinical trials—Industry payments18Ocular Therapeutix, Inc.Clinical trials—Industry payments13Astellas Pharma US IncClinical trials—Industry payments8Abbvie Inc.Clinical trials—Industry payments7Coherus Biosciences Inc.Clinical trials—Industry payments6Harrow Eye, LLCClinical trials—Industry payments6Sandoz Inc.Clinical trials—Industry payments5Alcon Vision LLCClinical trials—Industry payments4Bausch & Lomb, a division of Bausch Health US, LLCClinical trials—Industry payments4Horizon Therapeutics plcClinical trials—Industry payments4Novartis Pharmaceuticals CorporationClinical trials—Industry payments4Biogen, Inc.Clinical trials—Industry payments3EyePoint Pharmaceuticals US, Inc.Clinical trials—Industry payments3Allergan, Inc.Clinical trials—Industry payments2ANI Pharmaceuticals, Inc.Clinical trials—Industry payments2Genentech, Inc.Clinical trials—Industry payments2Notal Vision, Inc.Clinical trials—Industry payments2Retina Associates of Florida, P.A.Clinical trials2Industry payments—Astellas Pharma Global DevelopmentClinical trials—Industry payments1Cardinal Health 108 LLCClinical trials—Industry payments1Dompe US, Inc.Clinical trials—Industry payments1F. Hoffmann-La Roche AGClinical trials—Industry payments1Immunocore LimitedClinical trials—Industry payments1Johnson & Johnson Surgical Vision, Inc.Clinical trials—Industry payments1Oyster Point Pharma, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
64publications

Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.

3,839citations

Total citations across indexed works.

25h-index

Hirsch index (OpenAlex). i10-index 36.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
31companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

31 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    97.6%
    Antineovascularisation agents95.6%
    Faricimab-svoa100%
    Part B, office-administered≥236 patients
    Vascular Endothelial Growth Factor Inhibitor1.4%
    Ranibizumab100%
    Part B, office-administered≥43 patients

    + 5 more classes in this area

  • Cancer & immunology

    2.2%
    Complement Inhibitor1.7%
    Pegcetacoplan100%
    Part B, office-administered≥18 patients
    Vascular Endothelial Growth Factor Inhibitor0.5%
    Aflibercept100%
    Part B, office-administered≥43 patients
  • Anti-infectives

    0.1%
    Fluoroquinolone Antibacterial0.1%
    Moxifloxacin100%
    Part D≥43 patients
All 5 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Neil M. Bressler19Chantal Dolan18Rohit Varma13Paul P. Lee13Shoshana Colman12James Ward10Scott W. Cousins7Marc C. Peden7Roman G. Rubio6Jason S. Ehrlich5Diego G. Espinosa‐Heidmann5Adam Turpcu5Mark E. Hammer5J. Ward5Mark D. Danese3Seenu M. Hariprasad3Jennifer Fine3Tom Chang3P. Lee3Eleut P. Hernandez3Irwin Tran3Elizabeth Tschosik2Michael P. Miller2Paul Palmberg2Tsontcho Ianchulev2Daniel M. Miller2Allen C. Ho2Quan V. Doan2Janet R. Traynom2Jeffrey S. Heier2Paolo Lanzetta2Brandon Busbee2Audrey Kapre2Robyn H. Guymer2Sander R. Dubovy2Daniela Ferrara2W. Sanderson Grizzard2Linda Yau2Thomas R. Friberg2Sobha Sivaprasad2

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/ivan-suner-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/ivan-suner-476a8411

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Ivan-Suner

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/TampaRetina

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • LinkedIn

    LinkedIn: linkedin.com/in/ivan-suner-476a8411

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Diplomate

    American Board of Ophthalmology

    2018
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗
  • M.D.

    Yale University School of Medicine

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗
  • B.A.

    Magna cum laude, Harvard University

    1988
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗
  • MBA in Health Administration and Finance

    University of South Florida

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗

Editorial & leadership roles

journal and society appointments
  • President

    Association of Veterans Affairs Ophthalmologists

    2008
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medifind.com ↗
  • Oral Boards Examiner

    American Board of Ophthalmology

    2007
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗
  • Editorial Board member

    Ophthalmology Practice Options

    2006
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗
  • Editorial Board member

    Federal Practitioner

    2004
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗
  • Fellow

    American Society of Retina Specialists (FASRS)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Member

    The Retina Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗
  • Member

    Macula Society

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Clinical Associate Professor

    University of South Florida Department of Ophthalmology

    2010
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →retinaassociatesflorida.com ↗
  • Duke University

    Associate Professor (past, ORCID-declared)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗
  • University of Miami Health System / Bascom Palmer Eye Institute

    Assistant Professor of Ophthalmology (past)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗
  • United States Air Force

    Chief of Ophthalmology, Scott Air Force Base (past)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asrs.org ↗

Media & interviews

press, podcasts and appearances
  • Guest

    JVRD Author's Forum Podcast (ASRS) discussing "Coring of Intravitreal Medication Vial Stoppers"

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.